Literature DB >> 12205477

Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.

Tom H M Ottenhoff1, Frank A W Verreck, Elgin G R Lichtenauer-Kaligis, Marieke A Hoeve, Ozden Sanal, Jaap T van Dissel.   

Abstract

Host genetic factors are important in determining the outcome of infections caused by intracellular pathogens, including mycobacteria and salmonellae, but until now have been poorly characterized. Recently, some individuals with severe infections due to otherwise weakly pathogenic mycobacteria (non-tuberculous mycobacteria or Mycobacterium bovis bacille Calmette-Guérin) or Salmonella species have been shown to be unable to produce or respond to interferon-gamma. This inability results from mutations in any of five genes encoding essential proteins of the type 1 cytokine cascade: interleukin-12p40, interleukin-12R beta 1, interferon-gamma R1, interferon-gamma R2 or STAT1. Ten syndromes have thus far been identified. Recent insights in genetically controlled host defense and susceptibility to mycobacterial disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205477     DOI: 10.1038/ng0902-97

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  72 in total

1.  Host genetics and the dissection of mycobacterial immunity.

Authors:  G S Cooke; M R Siddiqui
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

2.  Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases.

Authors:  Y Doorduyn; W Van Pelt; C L E Siezen; F Van Der Horst; Y T H P Van Duynhoven; B Hoebee; R Janssen
Journal:  Epidemiol Infect       Date:  2007-12-07       Impact factor: 2.451

Review 3.  Host specificity of bacterial pathogens.

Authors:  Andreas Bäumler; Ferric C Fang
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

4.  Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections.

Authors:  Ozden Sanal; Tuba Turul; Tijtske De Boer; Esther Van de Vosse; Işik Yalcin; Ilhan Tezcan; Cağman Sun; L Memis; Tom H M Ottenhoff; Fugen Ersoy
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

Review 5.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection.

Authors:  Hongmei Kong; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

7.  Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.

Authors:  Tjitske de Boer; Jaap T van Dissel; Taco W J Kuijpers; Guus F Rimmelzwaan; Frank P Kroon; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

8.  Case Report: Disseminated Mycobacterium kansasii Disease in a Patient with Anti-Interferon-Gamma Antibody.

Authors:  Eriko Kashihara; Kohei Fujita; Naohiro Uchida; Yuki Yamamoto; Tadashi Mio; Hiroshi Koyama
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

9.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Marieke A Hoeve; Matthijs Kramer; Elena Vaisberg; Robert Kastelein; Arend Kolk; René de Waal-Malefyt; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

10.  Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.

Authors:  Sebastian D Schuck; Henrik Mueller; Frank Kunitz; Albert Neher; Harald Hoffmann; Kees L C M Franken; Dirk Repsilber; Tom H M Ottenhoff; Stefan H E Kaufmann; Marc Jacobsen
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.